AlphaYou
Overview
Smart money at a glance
Filings to Sep 26, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: both buying and selling, $3K to $45K in total in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- $3K to $45K tradedMixed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 2 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 25- Open
- $17.77
- 52-wk high
- $19.67
- High
- $17.88
- 52-wk low
- $13.22
- Low
- $17.61
- Prev close
- $17.67
- Mkt cap
- $33.82B
- P/E
- 20.7x
- Volume
- 17.49M
- Fwd P/E
- 14.7x
- Beta
- 0.43
- Div yield
- 4.70%
- P/S
- 2.2x
- P/B
- 3.2x
- Profit margin
- +10.8%
- Op margin
- +19.4%
- ROE
- +15.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about KVUE filings
Are insiders buying or selling Kenvue Inc. (KVUE) stock?
Neither. Kenvue Inc. (KVUE) insiders filed no open-market purchases or sales in the 90 days to Sep 26, 2026, according to SEC Form 4 filings.
Which members of Congress have traded KVUE recently?
Rep. Kevin Hern (R) sold $1K to $15K on Aug 5, 2026, disclosed 5 days later. Rep. Gilbert Cisneros (D) sold $1K to $15K on Jul 17, 2026, disclosed 49 days later. Rep. Gilbert Cisneros (D) bought $1K to $15K on Jun 16, 2026, disclosed 16 days later. In total, 2 members disclosed 3 KVUE trades with trade dates in the last 180 days, filed a median 16 days after trading.
How current is this KVUE smart-money data?
This summary uses filings available on Sep 26, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- SQ
Squarepoint
$50.9M
added
Sells/Trims (2)
- DS
D.E. Shaw
$307.6M
trimmed
- MW
Marshall Wace
$199.4M
trimmed
What insiders are doing
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
No tracked top-trader positions in KVUE right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 3.1% below what analysts expected.
Earnings per share
$0.32 expected
Revenue
$3.97B expected
GAAP EPS was $0.24 and adjusted EPS was $0.31. The analyst basis could not be confirmed, so no beat or miss is shown.
Reports Nov 2, 2026, in 37 days
EPS expected
$0.28 to $0.32
Revenue expected
9 analysts
Last 30 days
Analysts cutting estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.76B | $3.78B | $3.91B | $3.96B |
| Cost of what it sold | $1.54B | $1.64B | $1.61B | $1.65B |
| Gross profit | $2.23B | $2.14B | $2.30B | $2.30B |
| What it spent | ||||
| Research and development | — | — | $84.0M | — |
| Sales and admin | $1.51B | $1.53B | $1.45B | $1.54B |
| Other operating costs | $85.0M | -$223.0M | -$84.0M | $65.0M |
| Total operating expenses | $1.60B | $1.31B | $1.45B | $1.60B |
| What was left | ||||
| Operating profit | $629.0M | $825.0M | $855.0M | $699.0M |
| Interest on debt | $93.0M | $98.0M | $95.0M | $90.0M |
| Profit before tax | $526.0M | $427.0M | $672.0M | $598.0M |
| Tax | $128.0M | $97.0M | $198.0M | $142.0M |
| Net profit | $398.0M | $330.0M | $474.0M | $456.0M |
| EBITDA | $760.0M | $663.0M | $910.0M | $833.0M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Kenvue stock rises as Kimberly Clark advances its takeover bid
Leans bullishSep 23kimberly clark offers eu remedies for 40 billion kenvue deal
NeutralSep 23Nykredit A S Acquires Shares of 235,332 Kenvue Inc. $KVUE
NeutralSep 23Kenvue stock adds 1.1 percent ahead of the open
BullishSep 23Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal
Leans bullishSep 22Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal
Leans bullishSep 22Clorox vs. Kimberly-Clark: Which Household Staples Dividend Is Safer
Leans bearishSep 21Engineers Gate Manager LP Reduces Stock Position in Kenvue Inc. $KVUE
Leans bearishSep 20